腹腔热灌注化疗（HIPEC）

预约门诊
打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 查找姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 主动 查找姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 未找到姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 查找姓氏以该字母开头的医生 R
  19. 未找到姓氏以该字母开头的医生 S
  20. 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: G

研究

妙佑医疗国际综合癌症中心被美国国家癌症研究所指定为综合癌症中心，其正在癌症研究领域开拓新的边界，包括将腹腔热灌注化疗（HIPEC）用于胰腺癌和胃癌的治疗。妙佑医疗国际的外科医生也在改进机器人手术在减瘤术（CRS）中的应用。机器人手术通常能缩短许多患者的住院时间和恢复时间。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在腹腔热灌注化疗（HIPEC）领域的著述目录。

Research Profiles

编辑搜索过滤条件
close

缩小搜索范围

查看所有医生 • 所有位置

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

申请预约
关于在 Mayo Clinic 治疗
Oct. 25, 2025
打印
  1. Hyperthermic intraperitoneal chemotherapy. NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperthermic-intraperitoneal-chemotherapy. Accessed April 3, 2025.
  2. Van der Speeten K, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: HIPEC technologies. Annals of Surgical Oncology. 2024; doi:10.1245/s10434-024-15513-4.
  3. Bhatt A, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: Epithelial ovarian cancer. Annals of Surgical Oncology. 2023; doi:10.1245/s10434-023-13932-3.
  4. Kusamura S, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: Pseudomyxoma peritonei. Annals of Surgical Oncology. 2024; doi:10.1245/s10434-024-15646-6.
  5. Hübner M, et al. 2022 Peritoneal Surface Oncology Group international consensus on HIPEC regimens for peritoneal malignancies: Colorectal cancer. Annals of Surgical Oncology. 2024; doi:10.1245/s10434-023-14368-5.
  6. Hübner M, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS) society recommendations — Part I: Preoperative and intraoperative management. European Journal of Surgical Oncology. 2020; doi:10.1016/j.ejso.2020.07.041.
  7. Hübner M, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS) society recommendations — Part II: Postoperative management and special considerations. European Journal of Surgical Oncology. 2020; doi:10.1016/j.ejso.2020.08.006.
  8. Gearing PF, et al. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review. European Journal of Surgical Oncology. 2023; doi:10.1016/j.ejso.2023.02.015.
  9. Chen D, et al. Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis and systematic review. International Journal of Colorectal Disease. 2024; doi:10.1007/s00384-024-04741-5.
  10. Lewis AL, et al. Anesthesia for cytoreductive surgery with heated intraperitoneal chemotherapy. https://www.uptodate.com/contents/search. Accessed April 3, 2025.
  11. Ramirez PT, et al., eds. Hyperthermic intraperitoneal chemotherapy (HIPEC). In: Principles of Gynecologic Oncology Surgery. 2nd ed. Elsevier; 2025. https://www.clinicalkey.com. Accessed April 3, 2025.
  12. Hagberg C. Anesthesia and surgery for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). In: Perioperative Care of the Cancer Patient. Elsevier; 2023. https://www.clinicalkey.com. Accessed April 3, 2025.
  13. Karimi M, et al. Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: A comprehensive review of clinical outcomes. Frontiers in Surgery. 2024; doi:10.3389/fsurg.2024.1498529.
  14. Tsolakidis D, et al. Evaluating the impact of hyperthermic intraperitoneal chemotherapy (HIPEC) on interval and secondary debulking in ovarian cancer: A systematic review. Cancers. 2025; doi:10.3390/cancers17050904.
  15. Yang G, et al. Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: A six-year retrospective study. World Journal of Surgical Oncology. 2024; doi:10.1186/s12957-024-03598-w.
  16. Morgan RB, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A narrative review. Digestive Medicine Research. 2020; doi:10.21037/dmr-20-153.

相关

腹腔热灌注化疗（HIPEC）